Vir Biotechnology Inc. (VIR)
NASDAQ: VIR
· Real-Time Price · USD
4.94
-0.10 (-1.98%)
At close: Aug 29, 2025, 3:59 PM
5.00
1.21%
After-hours: Aug 29, 2025, 07:57 PM EDT
-1.98% (1D)
| Bid | 3.68 |
| Market Cap | 686.25M |
| Revenue (ttm) | 16.67M |
| Net Income (ttm) | -550.23M |
| EPS (ttm) | -4.01 |
| PE Ratio (ttm) | -1.23 |
| Forward PE | -1.72 |
| Analyst | Buy |
| Ask | 6.24 |
| Volume | 1,683,583 |
| Avg. Volume (20D) | 1,264,380 |
| Open | 5.02 |
| Previous Close | 5.04 |
| Day's Range | 4.86 - 5.11 |
| 52-Week Range | 4.16 - 14.45 |
| Beta | 1.18 |
Analyst Forecast
According to 0 analyst ratings, the average rating for VIR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Vir Biotechnology Inc. is scheduled to release its earnings on
Oct 30, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
6 days ago
+17.79%
Vir Biotechnology shares are trading higher after ...
Unlock content with
Pro Subscription
3 weeks ago
-0.59%
Vir Biotechnology shares are trading lower after the company reported worse-than-expected Q2 financial results.
6 days ago · https://thefly.com
BofA upgrades Vir Biotechnology to Buy on underappreciated HDV opportunityAs previously reported, BofA analyst Alec Stranahan upgraded Vir Biotechnology to Buy from Neutral with a price target of $14, up from $12, arguing that the market is underestimating the potential for...
